Centre for Neuroendocrine and Endocrine Tumours

Specialized Centre for Targeted Radionuklide Therapy  (e.g. 177Lu-DOTATOC) and  European Neuroendocrine Tumor Society (ENETS) Center of Excellence

Professor Damian Wild, Head of the Centre for Neuroendocrine and Endocrine Tumours

The Centre for Neuroendocrine and Endocrine Tumours at University Hospital Basel brings together the very best diagnostic, medical and surgical expertise for treating patients with neuroendocrine and endocrine cancer.

Neuroendocrine tumours are quite rare and can develop in many different organs of the body, but are most common in the digestive system. These tumours, some of which display hormonal activity, can have very different presenting features. Cancers with low malignancy potential, for example, can enter remission after local excision of the tumour, but more aggressive carcinomas require more intensive treatment for controlling the disease. Because they are rare and their characteristics vary so much, the diagnosis and treatment of these tumours generally requires  collaboration between specialists from many different disciplines.

Targeted Radionuclide Therapy is an internationally recognized speciality of our Centre. For example 90Y-DOTATOC and 177Lu-DOTATOC were both developed at the University Hospital Basel.

The most common endocrine tumours tend to be carcinomas of the thyroid gland, including medullary thyroid cancer. The growth rate of these highly differentiated thyroid carcinomas is relatively slow, and early diagnosis and effective treatment often produces an excellent long-term prognosis.

The mission of the Centre for Neuroendocrine and Endocrine Tumours is to combine the skills and experience of different specialist disciplines to diagnose and treat these generally rare forms of cancer and offer the patients affected accurate diagnosis and individual treatment based on the latest medical research.

Our priority is always on customised patient care that takes into consideration not only the medical possibilities, but also the personal needs and resources of each patient.

To optimise treatment outcomes, all our specialists meet regularly in “Tumour Boards”. We also work with other cancer centres in complex cases, by offering second opinions when producing individual treatment recommendations. Ultimately the success of treatment depends not least on close collaboration between referring colleagues, specialised oncology practices, and home nursing carers, as well as self-help groups and the patient’s own family.

The Centre for Neuroendocrine and Endocrine Tumours brings together the following clinics and institutes in the fields of medicine, surgery, specialist clinics and the University Hospital’s central support functions: Endocrinology, Oncology, Gastroenterology, Vascular surgery, ENT, Pathology, Radiology and Nuclear Medicine Clinic and Radio oncology.

Contact, Patient Services and Administration

Tel. +41 61 556 53 84
Fax +41 61 265 49 25




Centre Coordination


Management Board



  • Brigit Avis-Furler
    Chefarztsekretärin Nuklearmedizin, Radiopharmazeut. Chemie,
    Mitglied Tumorzentrum
    Tel.+41 61 556 53 84